Results
The proportions of patients who had a recurrence of atrial fibrillation after a mean follow-up of 16 months were:
- 35% for amiodarone
- 63% for sotalol/propafenone
- p < 0.001
Amiodarone resulted in a higher rate of adverse events necessitating discontinuation of therapy:
- 18% for amiodarone
- 11% for sotalol/propafenone
- p = 0.06
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.